Bluejay Diagnostics, Inc. financial data

Symbol
BJDX on Nasdaq
Location
Acton, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 07 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 384% % 10%
Debt-to-equity 25% % -22.07%
Return On Equity -147.49% % 5.3%
Return On Assets -117.97% % -0.12%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,814,133 shares -93.25%
Common Stock, Shares, Outstanding 1,639,133 shares -90.8%
Entity Public Float $1,700,000 USD -43.9%
Common Stock, Value, Issued $164 USD -90.8%
Weighted Average Number of Shares Outstanding, Basic 1,574,535 shares 724%
Weighted Average Number of Shares Outstanding, Diluted 1,574,535 shares 724%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $3,013,049 USD -28.35%
Selling and Marketing Expense $8,297 USD
General and Administrative Expense $3,962,004 USD 2.7%
Operating Income (Loss) $-6,975,868 USD 14%
Nonoperating Income (Expense) $125,207 USD
Net Income (Loss) Attributable to Parent $-6,850,661 USD 20%
Earnings Per Share, Basic 607 USD/shares 99%
Earnings Per Share, Diluted 607 USD/shares 99%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,082,268 USD -46.45%
Assets, Current $3,352,859 USD -48.95%
Property, Plant and Equipment, Net $1,393,989 USD -9.16%
Operating Lease, Right-of-Use Asset $134,683 USD -40.8%
Other Assets, Noncurrent $8,727 USD -63.02%
Assets $4,890,258 USD -41.46%
Accounts Payable, Current $161,162 USD -49.1%
Accrued Liabilities, Current $551,986 USD -50.58%
Liabilities, Current $1,148,913 USD 9.5%
Operating Lease, Liability, Noncurrent $42,990 USD -66.98%
Other Liabilities, Noncurrent $5,573 USD -41.52%
Liabilities $1,197,476 USD 0.72%
Retained Earnings (Accumulated Deficit) $-40,087,455 USD -20.61%
Stockholders' Equity Attributable to Parent $3,692,782 USD -48.46%
Liabilities and Equity $4,890,258 USD -41.46%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-1,184,857 USD 48%
Net Cash Provided by (Used in) Financing Activities $-985,000 USD -135.33%
Net Cash Provided by (Used in) Investing Activities $-35,433 USD 90%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 1,639,133 shares -90.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3,082,268 USD -46.45%
Deferred Tax Assets, Valuation Allowance $10,035,093 USD 30%
Deferred Tax Assets, Gross $10,035,093 USD 30%
Operating Lease, Liability $142,992 USD -40.83%
Depreciation $18,401 USD -6.66%
Payments to Acquire Property, Plant, and Equipment $35,433 USD -89.6%
Lessee, Operating Lease, Liability, to be Paid $150,000 USD -42.63%
Property, Plant and Equipment, Gross $1,513,479 USD -46.61%
Operating Lease, Liability, Current $100,002 USD -10.27%
Lessee, Operating Lease, Liability, to be Paid, Year Two $25,000 USD -75%
Lessee, Operating Lease, Liability, to be Paid, Year One $100,000 USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7,008 USD -64.61%
Lessee, Operating Lease, Liability, to be Paid, Year Three $25,000 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards $6,356,812 USD 40%
Lessee, Operating Lease, Liability, to be Paid, Year Four $25,000 USD -75%
Operating Lease, Payments $38,259 USD -13.47%
Additional Paid in Capital $28,726,487 USD 1.5%
Share-based Payment Arrangement, Expense $-2,650 USD -137.26%
Interest Expense $185,893 USD